Command Palette

Search for a command to run...

beryl-drugs

22.5-4.26%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Beryl Drugs Ltd. significantly lags behind its peers in terms of growth, profitability, and valuation metrics. Companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. exhibit strong profitability and growth, while Beryl shows no positive growth metrics and a high PE ratio compared to its peers. This positions Beryl as an underperformer in the Pharmaceuticals & Drugs sector.

Key Points
  • Beryl Drugs Ltd. shows zero revenue growth and no profitability metrics, making it a clear underperformer.
  • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. stand out as top performers with strong revenue growth and profitability ratios.
  • Companies like Sun Pharmaceutical Industries Ltd. and Divi's Laboratories Ltd. exhibit high valuations but vary in growth rates and profitability.
Top Performers
Cipla Ltd.

Strong revenue growth (13.28% YoY) and solid profitability with a PE of 23.73 and ROE of 16.63%.

Dr. Reddy's Laboratories Ltd.

Offers a balanced combination of growth (16.54% YoY) and low valuation metrics with a PE of 15.50.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.